Ravi Jain

Ravi Jain is a declared insider of Hemostemix Inc., with filings sourced from SEDI. We count 4 filings; the first trade dates from 30 November 2017 and the latest from 31 December 2018.

Sales make up the whole of the open-market record (3 sales, €5,256). So far in 2018, the count stands at no purchases and 3 sales.

The record was last updated on 31 December 2018 with an open-market sale (€2,402) in Hemostemix Inc. The median gap between trade and publication is zero days: most filings appear on the same day. The shorter that gap, the sooner other investors can see what insiders have done. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.